Nanovesicles for tumor-targeted drug delivery

Basit Öğe Kaydı
dc.authorscopusid57193741014
dc.authorscopusid57203248807
dc.authorscopusid57192876108
dc.authorscopusid56662137100
dc.authorscopusid35774636300
dc.authorscopusid57221835140
dc.contributor.authorKarpuz, Merve
dc.contributor.authorİlhan, Miray
dc.contributor.authorGültekin, Hazal Ezgi
dc.contributor.authorÖzgenç, Emre
dc.contributor.authorŞenyiğit, Zeynep
dc.contributor.authorAtlıhan Gündoğdu, Evren
dc.date.accessioned2023-07-26T11:51:10Z
dc.date.available2023-07-26T11:51:10Z
dc.date.issued2022
dc.departmentDÜ, Eczacılık Fakültesi, Eczacılık Teknolojisi Bölümüen_US
dc.description.abstractCancer is one of the most important burdens for the health systems worldwide due to cancer-related deaths associated with late diagnosis and treatment toxicities. Diagnosis of cancer plays a critical role in reducing cancer death rates as it facilitates early prognosis and treatment. Current cancer treatment mainly includes the resection of tumor tissue, radiation treatment, and pharmaceutical treatment. Although various techniques, methods, and drugs are clinically used in cancer diagnosis and treatment, they are inadequate for early diagnosis and effective treatment. Therefore, several studies regarding cancer-targeted nanosized drug delivery systems and theranostic approach are performed. Nanovesicular systems, one of the most important types of drug delivery systems, are formulated for the effective delivery and controlled release of active compounds such as drugs, genes, phytocompounds, and imaging agents. In this chapter, different types of nanovesicles are reviewed after providing information about conventional cancer imaging and treatment. Furthermore, targeting mechanisms of nanovesicles for cancer are explained. Finally, some studies performed to develop the nanovesicles as the imaging, treatment, or theranostic system for cancer are summarized. © 2022 Elsevier Inc. All rights reserved.en_US
dc.identifier.doi10.1016/B978-0-323-91865-7.00017-1
dc.identifier.endpage244en_US
dc.identifier.isbn9780323918657
dc.identifier.isbn9780323919531
dc.identifier.scopus2-s2.0-85142772080en_US
dc.identifier.startpage219en_US
dc.identifier.urihttps://doi.org/10.1016/B978-0-323-91865-7.00017-1
dc.identifier.urihttps://hdl.handle.net/20.500.12684/12509
dc.indekslendigikaynakScopusen_US
dc.institutionauthorİlhan, Miray
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.relation.ispartofApplications of Nanovesicular Drug Deliveryen_US
dc.relation.publicationcategoryKitap Bölümü - Uluslararasıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.snmz$2023V1Guncelleme$en_US
dc.subjectethosomesen_US
dc.subjectexosomesen_US
dc.subjectLiposomesen_US
dc.subjectnanovesiclesen_US
dc.subjectniosomesen_US
dc.subjectpolymersomesen_US
dc.subjecttheranosticen_US
dc.subjecttransfersomesen_US
dc.subjecttumor targetingen_US
dc.titleNanovesicles for tumor-targeted drug deliveryen_US
dc.typeBook Chapteren_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
12509-2.pdf
Boyut:
845.47 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
İndir

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu